HealthLynked Corp.
$1.94+$0.02 (+0.78%)
HealthLynked Corp.’s quoted price sits in the lower half of its reported 52-week range, 70.15% below the high.
OTC · CMPD · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
CompuMed, Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.89% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow CompuMed, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
CompuMed, Inc. functions as a dedicated provider of advanced telemedicine solutions tailored for organizational clients. The company extends vital clinical care services to both individual patients and various medical facilities internationally. Its primary specializations encompass telecardiology and teleradiology services. These enable healthcare institutions worldwide to connect in real-time with U.S. Board-Certified specialists, utilizing sophisticated cloud-based platforms and integrated medical equipment. Beyond these core areas, CompuMed offers extensive enterprise-level telemedicine frameworks. Its telecardiology portfolio includes a wide array of diagnostic interpretations for adult and pediatric patients, covering examinations such as electrocardiograms (ECG), echocardiograms, vascular studies, holter monitoring, nuclear cardiology assessments, and direct video consultations. In the realm of teleradiology, the company delivers expert image analysis, precise transcription, comprehensive reporting, secure data storage, and video consultations for modalities like Vscan, X-ray, ultrasound, mammography, computed tomography (CT), and magnetic resonance imaging (MRI). CompuMed also offers OsteoGram software, a specialized tool that integrates with both standard and digital X-ray systems to aid in the screening, diagnosis, and ongoing management of osteoporosis. Furthermore, the company supplies mobile ECG and ultrasound solutions, which grant patients direct and immediate access to its network of board-certified medical experts, in addition to providing various medical devices. Its clientele spans a diverse range of sectors, including organ procurement organizations, rural healthcare providers, and correctional healthcare facilities. CompuMed, Inc. was founded in 1973 and is based in Los Angeles, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:07 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.94+$0.02 (+0.78%)
HealthLynked Corp.’s quoted price sits in the lower half of its reported 52-week range, 70.15% below the high.
$0.06$0.00 (0.0%)
Reflect Scientific, Inc.’s quoted price sits in the upper half of its reported 52-week range, 17.24% below the high.
CA$0.01CA$0.00 (0.0%)
1933 Industries Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
CA$0.05CA$0.00 (0.0%)
Telo Genomics Corp.’s quoted price sits in the lower half of its reported 52-week range, 52.38% below the high.
A$0.01A$0.00 (0.0%)
Cann Group Limited’s quoted price sits in the lower half of its reported 52-week range, 61.54% below the high.
$0.05$0.00 (0.0%)
Vycor Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.0% below the high.
$0.01-$0.00 (-6.76%)
Dogecoin Cash, Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.96% below the high.
$0.14$0.00 (0.0%)
Mosaic ImmunoEngineering Inc.’s quoted price sits in the lower half of its reported 52-week range, 84.61% below the high.